Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2)
- PMID: 9613859
- DOI: 10.1002/(sici)1096-8628(19980328)81:2<179::aid-ajmg10>3.0.co;2-e
Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2)
Abstract
Smith-Magenis syndrome (SMS) is a distinct and clinically recognizable multiple congenital anomaly (MCA) and mental retardation syndrome caused by an interstitial deletion of chromosome 17 p11.2. The phenotype of SMS has been well described and includes: a characteristic pattern of physical features; a hoarse, deep voice; speech delay with or without associated hearing loss; signs of peripheral neuropathy; variable levels of mental retardation; and neurobehavioral problems. Although self-injury and sleep disturbance are major problems in SMS, studies are limited on the behavioral phenotype of SMS. This report reviews the current state of knowledge about SMS and presents new data based on syndrome-specific observations by the authors' longitudinal experience working with SMS, specifically related to the behavioral aspects of SMS. This information should have relevance for parents, clinicians, geneticists, and educators involved in the care of individuals with SMS.
Similar articles
-
Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2).Pediatr Neurol. 2006 May;34(5):337-50. doi: 10.1016/j.pediatrneurol.2005.08.018. Pediatr Neurol. 2006. PMID: 16647992 Review.
-
Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2).Am J Med Genet. 1998 Mar 28;81(2):186-91. Am J Med Genet. 1998. PMID: 9613860
-
[Speech impairment and the Smith-Magenis syndrome].HNO. 2007 Aug;55(8):644-6. doi: 10.1007/s00106-006-1430-7. HNO. 2007. PMID: 16767429 German.
-
Cognitive and adaptive behavior profiles in Smith-Magenis syndrome.J Dev Behav Pediatr. 2006 Jun;27(3):188-92. doi: 10.1097/00004703-200606000-00002. J Dev Behav Pediatr. 2006. PMID: 16775514
-
The neuropsychiatry and multisystem features of the Smith-Magenis syndrome: a review.J Neuropsychiatry Clin Neurosci. 2005 Winter;17(1):91-7. doi: 10.1176/jnp.17.1.91. J Neuropsychiatry Clin Neurosci. 2005. PMID: 15746488 Review.
Cited by
-
Functional and cellular characterization of human Retinoic Acid Induced 1 (RAI1) mutations associated with Smith-Magenis Syndrome.BMC Mol Biol. 2010 Aug 25;11:63. doi: 10.1186/1471-2199-11-63. BMC Mol Biol. 2010. PMID: 20738874 Free PMC article.
-
Abnormal melatonin synthesis in autism spectrum disorders.Mol Psychiatry. 2008 Jan;13(1):90-8. doi: 10.1038/sj.mp.4002016. Epub 2007 May 15. Mol Psychiatry. 2008. PMID: 17505466 Free PMC article.
-
Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.Genes (Basel). 2022 Feb 11;13(2):335. doi: 10.3390/genes13020335. Genes (Basel). 2022. PMID: 35205380 Free PMC article. Review.
-
Epigenetic Regulation and Neurodevelopmental Disorders: From MeCP2 to the TCF20/PHF14 Complex.Genes (Basel). 2024 Dec 23;15(12):1653. doi: 10.3390/genes15121653. Genes (Basel). 2024. PMID: 39766920 Free PMC article. Review.
-
Neurodevelopment of children under 3 years of age with Smith-Magenis syndrome.Pediatr Neurol. 2009 Oct;41(4):250-8. doi: 10.1016/j.pediatrneurol.2009.04.015. Pediatr Neurol. 2009. PMID: 19748044 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical